Eisai
4523.T
#1976
Rank
S$10.82 B
Marketcap
$38.24
Share price
-1.14%
Change (1 day)
-31.54%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $2.96

According to Eisai's latest financial reports the company's current EPS (TTM) is $2.94. In 2022 the company made an earnings per share (EPS) of $2.16 a decrease over its 2021 EPS that were of $9.57.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.9637.28%
2022$2.16-77.48%
2021$9.57-41.88%
2020$16.47-0.94%
2019$16.6352.59%
2018$10.90124.17%
2017$4.86-49.42%
2016$9.6137.08%
2015$7.01-11.75%
2014$7.94-3.23%
2013$8.21-18.56%
2012$10.08-15.51%
2011$11.93-3.75%
2010$12.40-1.36%
2009$12.57